Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-11 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
SLDB | Solid Biosciences | 8.01 | -1.20 | -13.03% | 679M |
You can purchase shares of Solid Biosciences (NASDAQ: SLDB) through any online brokerage.
Other companies in Solid Biosciences’s space includes: KalVista Pharmaceuticals (NASDAQ:KALV), Curis (NASDAQ:CRIS) and Chinook Therapeutics (NASDAQ:KDNY).
The latest price target for Solid Biosciences (NASDAQ: SLDB) was reported by Credit Suisse on 2021-01-08. The analyst firm set a price target for 7.00 expecting SLDB to fall to within 12 months (a possible -12.61% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Solid Biosciences (NASDAQ: SLDB) is $8.01 last updated Thu Feb 25 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Solid Biosciences.
There is no upcoming split for Solid Biosciences.